• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form SC 13D/A filed by Cross Country Healthcare Inc. (Amendment)

    10/28/22 4:22:40 PM ET
    $CCRN
    Professional Services
    Consumer Discretionary
    Get the next $CCRN alert in real time by email
    SC 13D/A 1 sc13da107902010_10282022.htm AMENDMENT NO. 1 TO THE SCHEDULE 13D

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    Washington, D.C. 20549

    SCHEDULE 13D

    (Rule 13d-101)

    INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT

    TO § 240.13d-1(a) AND AMENDMENTS THERETO FILED PURSUANT TO

    § 240.13d-2(a)

    (Amendment No. 1)1

    Cross Country Healthcare, Inc.

    (Name of Issuer)

    Common Stock, par value $0.0001 per share

    (Title of Class of Securities)

    227483104

    (CUSIP Number)

    JEFFREY JACOBOWITZ

    SIMCOE CAPITAL MANAGEMENT, LLC

    540 Madison Avenue, 27th Floor

    New York, New York 10022

    (212) 448-7400

     

    STEVE WOLOSKY, ESQ.

    OLSHAN FROME WOLOSKY LLP

    1325 Avenue of the Americas

    New York, New York 10019

    (212) 451-2300

    (Name, Address and Telephone Number of Person

    Authorized to Receive Notices and Communications)

     

    October 26, 2022

    (Date of Event Which Requires Filing of This Statement)

     

    If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§ 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box ¨.

    Note:  Schedules filed in paper format shall include a signed original and five copies of the schedule, including all exhibits.  See § 240.13d-7 for other parties to whom copies are to be sent.

     

     

     

    1              The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.

    The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

     

    CUSIP No. 227483104

      1   NAME OF REPORTING PERSON  
             
            SIMCOE CAPITAL MANAGEMENT, LLC  
      2   CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) ☐
            (b) ☐
               
      3   SEC USE ONLY    
               
               
      4   SOURCE OF FUNDS  
             
            AF  
      5   CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEM 2(d) OR 2(e)     ☐
           
               
      6   CITIZENSHIP OR PLACE OF ORGANIZATION  
             
            DELAWARE  
    NUMBER OF   7   SOLE VOTING POWER  
    SHARES          
    BENEFICIALLY         1,613,581  
    OWNED BY   8   SHARED VOTING POWER  
    EACH          
    REPORTING         - 0 -  
    PERSON WITH   9   SOLE DISPOSITIVE POWER  
             
              1,613,581  
        10   SHARED DISPOSITIVE POWER  
               
              - 0 -  
      11   AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON  
             
            1,613,581  
      12   CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES     ☐
           
               
      13   PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)  
             
            4.2%  
      14   TYPE OF REPORTING PERSON  
             
            OO  

      

    2

    CUSIP No. 227483104

      1   NAME OF REPORTING PERSON  
             
            SIMCOE PARTNERS, L.P.  
      2   CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) ☐
            (b) ☐
               
      3   SEC USE ONLY    
               
               
      4   SOURCE OF FUNDS  
             
            WC  
      5   CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEM 2(d) OR 2(e)     ☐
           
               
      6   CITIZENSHIP OR PLACE OF ORGANIZATION  
             
            DELAWARE  
    NUMBER OF   7   SOLE VOTING POWER  
    SHARES          
    BENEFICIALLY         1,472,375  
    OWNED BY   8   SHARED VOTING POWER  
    EACH          
    REPORTING         - 0 -  
    PERSON WITH   9   SOLE DISPOSITIVE POWER  
             
              1,472,375  
        10   SHARED DISPOSITIVE POWER  
               
              - 0 -  
      11   AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON  
             
            1,472,375  
      12   CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES     ☐
           
               
      13   PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)  
             
            3.9%  
      14   TYPE OF REPORTING PERSON  
             
            PN  

      

    3

    CUSIP No. 227483104

     

      1   NAME OF REPORTING PERSON  
             
            SIMCOE SELECT, L.P.  
      2   CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) ☐
            (b) ☐
               
      3   SEC USE ONLY    
               
               
      4   SOURCE OF FUNDS  
             
            WC  
      5   CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEM 2(d) OR 2(e)     ☐
           
               
      6   CITIZENSHIP OR PLACE OF ORGANIZATION  
             
            DELAWARE  
    NUMBER OF   7   SOLE VOTING POWER  
    SHARES          
    BENEFICIALLY         82,403  
    OWNED BY   8   SHARED VOTING POWER  
    EACH          
    REPORTING         - 0 -  
    PERSON WITH   9   SOLE DISPOSITIVE POWER  
             
              82,403  
        10   SHARED DISPOSITIVE POWER  
               
              - 0 -  
      11   AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON  
             
            82,403  
      12   CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES     ☐
           
               
      13   PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)  
             
            Less than 1%  
      14   TYPE OF REPORTING PERSON  
             
            PN  

      

    4

    CUSIP No. 227483104

     

      1   NAME OF REPORTING PERSON  
             
            SIMCOE MANAGEMENT COMPANY, LLC  
      2   CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) ☐
            (b) ☐
               
      3   SEC USE ONLY    
               
               
      4   SOURCE OF FUNDS  
             
            AF  
      5   CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEM 2(d) OR 2(e)     ☐
           
               
      6   CITIZENSHIP OR PLACE OF ORGANIZATION  
             
            DELAWARE  
    NUMBER OF   7   SOLE VOTING POWER  
    SHARES          
    BENEFICIALLY         1,554,778  
    OWNED BY   8   SHARED VOTING POWER  
    EACH          
    REPORTING         - 0 -  
    PERSON WITH   9   SOLE DISPOSITIVE POWER  
             
              1,554,778  
        10   SHARED DISPOSITIVE POWER  
               
              - 0 -  
      11   AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON  
             
            1,554,778  
      12   CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES     ☐
           
               
      13   PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)  
             
            4.1%  
      14   TYPE OF REPORTING PERSON  
             
            OO  

      

    5

    CUSIP No. 227483104

     

      1   NAME OF REPORTING PERSON  
             
            SDR PARTNERS, LLC  
      2   CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) ☐
            (b) ☐
               
      3   SEC USE ONLY    
               
               
      4   SOURCE OF FUNDS  
             
            WC  
      5   CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEM 2(d) OR 2(e)     ☐
           
               
      6   CITIZENSHIP OR PLACE OF ORGANIZATION  
             
            DELAWARE  
    NUMBER OF   7   SOLE VOTING POWER  
    SHARES          
    BENEFICIALLY         58,803  
    OWNED BY   8   SHARED VOTING POWER  
    EACH          
    REPORTING         - 0 -  
    PERSON WITH   9   SOLE DISPOSITIVE POWER  
             
              58,803  
        10   SHARED DISPOSITIVE POWER  
               
              - 0 -  
      11   AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON  
             
            58,803  
      12   CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES     ☐
           
               
      13   PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)  
             
            Less than 1%  
      14   TYPE OF REPORTING PERSON  
             
            OO  

      

    6

    CUSIP No. 227483104

     

      1   NAME OF REPORTING PERSON  
             
            JEFFREY JACOBOWITZ  
      2   CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) ☐
            (b) ☐
               
      3   SEC USE ONLY    
               
               
      4   SOURCE OF FUNDS  
             
            AF  
      5   CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEM 2(d) OR 2(e)     ☐
           
               
      6   CITIZENSHIP OR PLACE OF ORGANIZATION  
             
            USA  
    NUMBER OF   7   SOLE VOTING POWER  
    SHARES          
    BENEFICIALLY         1,613,581  
    OWNED BY   8   SHARED VOTING POWER  
    EACH          
    REPORTING         - 0 -  
    PERSON WITH   9   SOLE DISPOSITIVE POWER  
             
              1,613,581  
        10   SHARED DISPOSITIVE POWER  
               
              - 0 -  
      11   AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON  
             
            1,613,581  
      12   CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES     ☐
           
               
      13   PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)  
             
            4.2%  
      14   TYPE OF REPORTING PERSON  
             
            IN  

      

    7

    CUSIP No. 227483104

    The following constitutes Amendment No. 1 to the Schedule 13D filed by the undersigned (“Amendment No. 1”). This Amendment No. 1 amends the Schedule 13D as specifically set forth herein.

    Item 3.Source and Amount of Funds or Other Consideration.

    Item 3 is hereby amended and restated to read as follows:

    The Shares purchased by each of Simcoe Partners, Simcoe Select and SDR Partners were purchased with working capital (which may, at any given time, include margin loans made by brokerage firms in the ordinary course of business) in open market purchases. The aggregate purchase price of the 1,472,375 Shares directly owned by Simcoe Partners is approximately $22,232,109, including brokerage commissions. The aggregate purchase price of the 82,403 Shares directly owned by Simcoe Select is approximately $1,553,088 including brokerage commissions. The aggregate purchase price of the 58,803 Shares directly owned by SDR Partners is approximately $1,224,545, including brokerage commissions.

    Item 5.Interest in Securities of the Issuer.

    Item 5 is hereby amended and restated to read as follows:

    The aggregate percentage of Shares reported owned by each person named herein is based upon 38,231,338 Shares outstanding, as of July 21, 2022, which is the total number of Shares outstanding as reported in the Issuer’s Quarterly Report on Form 10-Q filed with the Securities and Exchange Commission on August 4, 2022.

    A.Simcoe Partners
    (a)As of the date hereof, Simcoe Partners directly owned 1,472,375 Shares.

    Percentage: 3.9%

    (b)1. Sole power to vote or direct vote: 1,472,375
    2. Shared power to vote or direct vote: 0
    3. Sole power to dispose or direct the disposition: 1,472,375
    4. Shared power to dispose or direct the disposition: 0

     

    (c)The transactions in the Shares by Simcoe Partners since the filing of the Schedule 13D are set forth in Schedule A and are incorporated herein by reference.
    B.Simcoe Select
    (a)As of the date hereof, Simcoe Select directly owned 82,403 Shares.

    Percentage: Less than 1%

    (b)1. Sole power to vote or direct vote: 82,403
    2. Shared power to vote or direct vote: 0
    3. Sole power to dispose or direct the disposition: 82,403
    4. Shared power to dispose or direct the disposition: 0

     

    (c)The transactions in the Shares by Simcoe Select since the filing of the Schedule 13D are set forth in Schedule A and are incorporated herein by reference.
    8

    CUSIP No. 227483104

    C.Simcoe Management
    (a)Simcoe Management, as the general partner of Simcoe Partners and Simcoe Select, may be deemed the beneficial owner of the (i) 1,472,375 Shares owned by Simcoe Partners and (ii) 82,403 Shares owned by Simcoe Select.

    Percentage: 4.1%

    (b)1. Sole power to vote or direct vote: 1,554,778
    2. Shared power to vote or direct vote: 0
    3. Sole power to dispose or direct the disposition: 1,554,778

    4. Shared power to dispose or direct the disposition: 0

     

    (c)Simcoe Management has not entered into any transactions in the Shares during the past sixty days. The transactions in the Shares on behalf of Simcoe Partners and Simcoe Select since the filing of the Schedule 13D are set forth in Schedule A and are incorporated herein by reference.
    D.SDR Partners
    (a)As of the date hereof, SDR Partners directly owned 58,803 Shares.

    Percentage: Less than 1%

    (b)1. Sole power to vote or direct vote: 58,803
    2. Shared power to vote or direct vote: 0
    3. Sole power to dispose or direct the disposition: 58,803
    4. Shared power to dispose or direct the disposition: 0

     

    (c)The transactions in the Shares by SDR Partners since the filing of the Schedule 13D are set forth in Schedule A and are incorporated herein by reference.
    E.Simcoe Capital
    (a)Simcoe Capital, as the investment manager to each of Simcoe Partners, Simcoe Select and SDR Partners, may be deemed the beneficial owner of the (i) 1,472,375 Shares owned by Simcoe Partners, (ii) 82,403 Shares owned by Simcoe Select and (iii) 58,803 Shares owned by SDR Partners.

    Percentage: 4.2%

    (b)1. Sole power to vote or direct vote: 1,613,581
    2. Shared power to vote or direct vote: 0
    3. Sole power to dispose or direct the disposition: 1,613,581

    4. Shared power to dispose or direct the disposition: 0

     

    (c)Simcoe Capital has not entered into any transactions in the Shares since the filing of the Schedule 13D. The transactions in the Shares on behalf of each of Simcoe Partners, Simcoe Select and SDR Partners since the filing of the Schedule 13D are set forth in Schedule A and are incorporated herein by reference.
    9

    CUSIP No. 227483104

    F.Mr. Jacobowitz
    (a)Mr. Jacobowitz, as Managing Member of each of Simcoe Management and Simcoe Capital, may be deemed the beneficial owner of the (i) 1,472,375 Shares owned by Simcoe Partners (ii) 82,403 Shares owned by Simcoe Select and (iii) 58,803 Shares owned by SDR Partners.

    Percentage: 4.2%

    (b)1. Sole power to vote or direct vote: 1,613,581
    2. Shared power to vote or direct vote: 0
    3. Sole power to dispose or direct the disposition: 1,613,581

    4. Shared power to dispose or direct the disposition: 0

     

    (c)Mr. Jacobowitz has not entered into any transactions in the Shares since the filing of the Schedule 13D. The transactions in the Shares on behalf of each of Simcoe Partners, Simcoe Select and SDR Partners since the filing of the Schedule 13D are set forth in Schedule A and are incorporated herein by reference.

    Each Reporting Person, as a member of a “group” with the other Reporting Persons for the purposes of Section 13(d)(3) of the Securities Exchange Act of 1934, as amended, may be deemed the beneficial owner of the Shares directly owned by the other Reporting Persons. Each Reporting Person disclaims beneficial ownership of such Shares except to the extent of his or its pecuniary interest therein.

    (d)No person other than the Reporting Persons is known to have the right to receive, or the power to direct the receipt of dividends from, or proceeds from the sale of, the Shares.
    (e)As of October 26, 2022, the Reporting Persons ceased to beneficially own more than 5% of the outstanding Shares of the Issuer.

     

    10

    CUSIP No. 227483104

    SIGNATURES

    After reasonable inquiry and to the best of his knowledge and belief, each of the undersigned certifies that the information set forth in this statement is true, complete and correct.

    Dated: October 28, 2022

      Simcoe Partners, L.P.
       
      By:

    Simcoe Management Company, LLC

    General Partner

         
      By: /s/ Jeffrey Jacobowitz
        Name: Jeffrey Jacobowitz
        Title: Managing Member

     

      Simcoe Select, L.P.
       
      By:

    Simcoe Management Company, LLC

    General Partner

         
      By: /s/ Jeffrey Jacobowitz
        Name: Jeffrey Jacobowitz
        Title: Managing Member

     

      Simcoe Management Company, LLC
       
      By: /s/ Jeffrey Jacobowitz
        Name: Jeffrey Jacobowitz
        Title: Managing Member

     

      SDR Partners, LLC
       
      By:

    Simcoe Capital Management, LLC

    Investment Manager

         
      By: /s/ Jeffrey Jacobowitz
        Name: Jeffrey Jacobowitz
        Title: Managing Member

     

      Simcoe Capital Management, LLC
       
      By: /s/ Jeffrey Jacobowitz
        Name: Jeffrey Jacobowitz
        Title: Managing Member

     

      /s/ Jeffrey Jacobowitz
      Jeffrey Jacobowitz

     

    11

    CUSIP No. 227483104

    SCHEDULE A

    Transactions in the Shares Since the Filing of the Schedule 13D

    Shares of Common Stock

    Purchased/(Sold)

    Price Per

    Share($)

    Date of

    Purchase/Sale

     

    SIMCOE PARTNERS, L.P.

     

    (113,458) 37.3359 10/24/2022
    (170,966) 36.3908 10/25/2022
    (214,791) 36.7828 10/26/2022
    (98,610) 36.6694 10/27/2022

     

    SIMCOE SELECT, L.P.

     

    (7,669) 37.3359 10/24/2022
    (11,555) 36.3908 10/25/2022
    (14,518) 36.7828 10/26/2022
    (11,029) 36.6694 10/27/2022

     

    SDR PARTNERS, LLC

     

    (3,873) 37.3359 10/24/2022
    (5,837) 36.3908 10/25/2022
    (7,333) 36.7828 10/26/2022
    (4,878) 36.6694 10/27/2022

     

    Get the next $CCRN alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $CCRN

    DatePrice TargetRatingAnalyst
    3/5/2026$14.00Hold → Buy
    The Benchmark Company
    2/3/2026$11.00Neutral
    Wedbush
    12/4/2025$11.00Mkt Perform → Mkt Outperform
    Citizens JMP
    12/10/2024Outperform → Mkt Perform
    Barrington Research
    12/6/2023Mkt Perform
    JMP Securities
    11/3/2023$32.00 → $21.00Buy → Hold
    Jefferies
    6/26/2023Outperform
    William Blair
    3/10/2023$30.00Buy
    Loop Capital
    More analyst ratings

    $CCRN
    SEC Filings

    View All

    Cross Country Healthcare Inc. filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits

    8-K - CROSS COUNTRY HEALTHCARE INC (0001141103) (Filer)

    3/10/26 4:12:04 PM ET
    $CCRN
    Professional Services
    Consumer Discretionary

    SEC Form 10-K filed by Cross Country Healthcare Inc.

    10-K - CROSS COUNTRY HEALTHCARE INC (0001141103) (Filer)

    3/9/26 6:25:36 AM ET
    $CCRN
    Professional Services
    Consumer Discretionary

    Cross Country Healthcare Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits

    8-K - CROSS COUNTRY HEALTHCARE INC (0001141103) (Filer)

    3/4/26 4:27:33 PM ET
    $CCRN
    Professional Services
    Consumer Discretionary

    $CCRN
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Cross Country Healthcare and Open Hearts for Orphans Announce Community Partnership to Strengthen Families and Support Vulnerable Children

    Cross Country Healthcare, Inc. (NASDAQ:CCRN), a technology-driven healthcare workforce solutions company delivering an AI-powered digital platform and advisory services backed by nearly 40 years of healthcare labor expertise, today announced a new community partnership with Open Hearts for Orphans (OHFO), a South Florida nonprofit dedicated to providing hope, healing, and family for orphaned and vulnerable children. This partnership brings together two mission-driven organizations committed to strengthening families, supporting communities, and improving outcomes for vulnerable children and the caregivers who support them. Through this collaboration, Cross Country will support OHFO thro

    3/10/26 7:30:00 AM ET
    $CCRN
    Professional Services
    Consumer Discretionary

    Cross Country Healthcare Announces Fourth Quarter and Full Year 2025 Financial Results

    Cross Country Healthcare, Inc. (the "Company," "Cross Country," "we," "us," and "our") (NASDAQ:CCRN) today announced financial results for its fourth quarter and full year ended December 31, 2025. SELECTED FINANCIAL INFORMATION: Dollars are in thousands, except per share amounts Q4 2025 Variance Q4 2025 vs Q4 2024 Variance Q4 2025 vs Q3 2025 Full Year 2025 Variance 2025 vs 2024 Revenue $ 236,761       (24 ) %   (5 ) % $ 1,054,293       (22 ) % Gross profit margin*   20.3   %   30

    3/4/26 4:15:00 PM ET
    $CCRN
    Professional Services
    Consumer Discretionary

    Cross Country Healthcare to Attend the Truist Securities Virtual Human Capital Conference and the Oppenheimer 36th Annual Healthcare Medtech & Services Conference

    Cross Country Healthcare, Inc. (the "Company") (NASDAQ:CCRN) announced today that it is scheduled to participate in two upcoming conferences: The Truist Securities Virtual Human Capital Conference taking place March 12-13, 2026, with one-on-one investor meetings on Thursday, March 12. The Oppenheimer 36th Annual Healthcare MedTech & Services Conference taking place March 16-19, 2026, with one-on-one investor meetings on Tuesday, March 17. In attendance and participating in one-on-ones at both conferences will be William J. Burns, Executive Vice President & Chief Financial Officer and Josh Vogel, Vice President, Investor Relations. No formal presentation will be made at either confe

    2/23/26 4:15:00 PM ET
    $CCRN
    Professional Services
    Consumer Discretionary

    $CCRN
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Cross Country upgraded by The Benchmark Company with a new price target

    The Benchmark Company upgraded Cross Country from Hold to Buy and set a new price target of $14.00

    3/5/26 8:22:11 AM ET
    $CCRN
    Professional Services
    Consumer Discretionary

    Wedbush initiated coverage on Cross Country with a new price target

    Wedbush initiated coverage of Cross Country with a rating of Neutral and set a new price target of $11.00

    2/3/26 8:08:13 AM ET
    $CCRN
    Professional Services
    Consumer Discretionary

    Cross Country upgraded by Citizens JMP with a new price target

    Citizens JMP upgraded Cross Country from Mkt Perform to Mkt Outperform and set a new price target of $11.00

    12/4/25 1:31:31 PM ET
    $CCRN
    Professional Services
    Consumer Discretionary

    $CCRN
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Cash W Larry bought $40,829 worth of shares (5,000 units at $8.17), increasing direct ownership by 3% to 204,632 units (SEC Form 4)

    4 - CROSS COUNTRY HEALTHCARE INC (0001141103) (Issuer)

    12/9/25 4:08:59 PM ET
    $CCRN
    Professional Services
    Consumer Discretionary

    Director Cash W Larry bought $61,320 worth of shares (6,000 units at $10.22), increasing direct ownership by 3% to 199,632 units (SEC Form 4)

    4 - CROSS COUNTRY HEALTHCARE INC (0001141103) (Issuer)

    12/31/24 5:15:10 PM ET
    $CCRN
    Professional Services
    Consumer Discretionary

    $CCRN
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    New insider Hawkins Amiee Lin claimed ownership of 29,273 shares (SEC Form 3)

    3 - CROSS COUNTRY HEALTHCARE INC (0001141103) (Issuer)

    2/18/26 5:05:32 PM ET
    $CCRN
    Professional Services
    Consumer Discretionary

    Amendment: General Counsel and Secretary Ball Susan E covered exercise/tax liability with 9,386 shares, decreasing direct ownership by 5% to 176,032 units (SEC Form 4)

    4/A - CROSS COUNTRY HEALTHCARE INC (0001141103) (Issuer)

    1/12/26 10:43:34 AM ET
    $CCRN
    Professional Services
    Consumer Discretionary

    Director Nevin Janice Elizabeth was granted 18,680 shares, increasing direct ownership by 62% to 48,616 units (SEC Form 4)

    4 - CROSS COUNTRY HEALTHCARE INC (0001141103) (Issuer)

    12/22/25 7:24:05 AM ET
    $CCRN
    Professional Services
    Consumer Discretionary

    $CCRN
    Leadership Updates

    Live Leadership Updates

    View All

    Cross Country Healthcare Announces CEO Transition

    Co-Founder and Chairman, Kevin C. Clark, Returns as Chief Executive Officer Cross Country Healthcare, Inc. (the "Company" and "Cross Country") (NASDAQ:CCRN) today announced that John A. Martins, the Company's President and Chief Executive Officer, has separated from the Company and ceased to serve as a member of its Board of Directors (the "Board"), effective as of December 14, 2025. The Board appointed Kevin C. Clark, the Company's current Chairman, former Chief Executive Officer, and Co-Founder, to succeed Mr. Martins as the Company's President and Chief Executive Officer. Mr. Clark will continue to serve as the Chairman of the Board. "The Board members are thrilled to have Kevin return

    12/15/25 8:15:00 AM ET
    $CCRN
    Professional Services
    Consumer Discretionary

    Aya Healthcare to Acquire Cross Country Healthcare for Approximately $615 Million in Cash

    Cross Country stockholders to receive $18.61 per share Expands Aya's client service and delivery capabilities with Cross Country's nearly 40-year history of clinical excellence and quality patient care Provides clinicians with greater flexibility and convenience by tapping into the combined pool of nationwide opportunities, with competitive compensation and a world-class experience Creates immediate stockholder value for Cross Country, through a nearly 67 percent premium Aya Healthcare and Cross Country Healthcare today announced that they have entered into a definitive agreement whereby Aya will acquire Cross Country for $18.61 per share in cash in a transaction valued at appr

    12/4/24 7:45:00 AM ET
    $CCRN
    Professional Services
    Consumer Discretionary

    The Ensign Group Set to Join S&P MidCap 400; Curbline Properties & TransMedics Group to Join S&P SmallCap 600

    NEW YORK, Sept. 26, 2024 /PRNewswire/ -- S&P Dow Jones Indices will make the following changes to the S&P SmallCap 600 and S&P MidCap 400: S&P SmallCap 600 constituent The Ensign Group Inc. (NASD: ENSG) will replace Southwestern Energy Co. (NYSE:SWN) in the S&P MidCap 400 and TransMedics Group, Inc. (NASD: TMDX) will replace The Ensign Group in the S&P SmallCap 600 effective prior to the opening of trading on Tuesday, October 1.  S&P MidCap 400 constituent Chesapeake Energy Corp. (NASD: CHK) is acquiring Southwestern Energy in a deal expected to be completed October 1.Curbline Properties Corp. (NYSE:CURB) will be added to the S&P SmallCap 600 effective prior to the open of trading on Tuesda

    9/26/24 6:04:00 PM ET
    $CCRN
    $CHK
    $ENSG
    Professional Services
    Consumer Discretionary
    Oil & Gas Production
    Energy

    $CCRN
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Cross Country Healthcare Inc.

    SC 13G/A - CROSS COUNTRY HEALTHCARE INC (0001141103) (Subject)

    11/13/24 9:39:57 PM ET
    $CCRN
    Professional Services
    Consumer Discretionary

    Amendment: SEC Form SC 13G/A filed by Cross Country Healthcare Inc.

    SC 13G/A - CROSS COUNTRY HEALTHCARE INC (0001141103) (Subject)

    11/13/24 4:36:10 PM ET
    $CCRN
    Professional Services
    Consumer Discretionary

    SEC Form SC 13G/A filed by Cross Country Healthcare Inc. (Amendment)

    SC 13G/A - CROSS COUNTRY HEALTHCARE INC (0001141103) (Subject)

    2/13/24 5:02:31 PM ET
    $CCRN
    Professional Services
    Consumer Discretionary

    $CCRN
    Financials

    Live finance-specific insights

    View All

    Cross Country Healthcare Announces Fourth Quarter and Full Year 2025 Financial Results

    Cross Country Healthcare, Inc. (the "Company," "Cross Country," "we," "us," and "our") (NASDAQ:CCRN) today announced financial results for its fourth quarter and full year ended December 31, 2025. SELECTED FINANCIAL INFORMATION: Dollars are in thousands, except per share amounts Q4 2025 Variance Q4 2025 vs Q4 2024 Variance Q4 2025 vs Q3 2025 Full Year 2025 Variance 2025 vs 2024 Revenue $ 236,761       (24 ) %   (5 ) % $ 1,054,293       (22 ) % Gross profit margin*   20.3   %   30

    3/4/26 4:15:00 PM ET
    $CCRN
    Professional Services
    Consumer Discretionary

    Cross Country Healthcare to Hold Fourth Quarter and Full Year 2025 Earnings Conference Call on Wednesday, March 4, 2026

    Cross Country Healthcare, Inc. (NASDAQ:CCRN) will hold its quarterly conference call to discuss its fourth quarter and full year 2025 financial results on Wednesday, March 4, 2026 at 5:00 P.M. Eastern Time. Cross Country Healthcare, Inc. (the "Company") intends to distribute its earnings press release after market close on Wednesday, March 4, 2026. This call will be webcast live and can be accessed at the Company's website at ir.crosscountry.com or by dialing 800-369-2163 from anywhere in the U.S. or by dialing 773-756-4715 from non-U.S. locations – Passcode: Cross Country. A replay of the webcast will be available from March 4th through March 18th on the Company's website and a replay of

    2/12/26 4:15:00 PM ET
    $CCRN
    Professional Services
    Consumer Discretionary

    Cross Country Healthcare Announces Third Quarter 2025 Financial Results

    Cross Country Healthcare, Inc. (the Company) (NASDAQ:CCRN) today announced financial results for its third quarter ended September 30, 2025. Selected Financial Information:     Variance Variance     Q3 2025 vs Q3 2025 vs Dollars are in thousands, except per share amounts Q3 2025 Q3 2024 Q2 2025 Revenue $ 250,052     (21 )%   (9 )% Gross profit margin*   20.4 %   — bps   — bps Net loss attributable to common stockholders $ (4,774 )   (287 )%

    11/12/25 4:56:00 PM ET
    $CCRN
    Professional Services
    Consumer Discretionary